Skip to main content

Inovio Pharmaceuticals expects to finish recruiting coronavirus vaccine volunteers by the end of April, CEO says

"We expect to finish enrollment of all 40 volunteers before the end of April," Inovio CEO Dr. Joseph Kim told CNBC. The biotech firm has begun phase one trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.